We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Almac Sciences, a member of the Almac Group, has secured $2.74 million of support from Invest Northern Ireland (Invest NI) to accelerate a program of enzyme research.
Almac Clinical Services to provide clinical trial services from protocol through to patient delivery, and Almac Sciences will provide analytical support.